Clinical analysis on the nosocomial infections in intensive care unit

doi:10.3969/j.issn.1006-7795.2018.01.008

Abstract

Abstract: Objective The study was conducted to analyze the pathogen division and drug resistance of nosocomial infection in intensive care unit (ICU), and to provide advice for the clinical application of antibiotics.Methods A retrospective survey was conducted to analyze the results of pathogens and drug susceptibility test in the patients hospitalized in ICU Beijing Friendship Hospital,Capital Medical University and contracting hospital infection during the period from January 1, 2015 to December 31, 2016.Results A total of 363 cases were reported during 2 years, out of which 271 strains were isolated. The top 5 pathogens were Klebsiella pneumoniae (16.97%), Acinetobacter baumannii (13.28%), Pseudomonas aeruginosa (12.18%), Enterococcus faecium (10.7%), and Staphylococcus aureus (5.9%).The top three infection sites were lower respiratory tract (55.7%), blood (17.6%),abdominal pelvic tissue(9.9%). The incidence of Klebsiella pneumonia in 2016 was significantly higher than that in 2015 (P<0.05).Conclusion During the study period, the most common part of nosocomial infection in ICU was in the lower respiratory tract. The incidence of Klebsiella pneumoniae increased significantly suggesting that antibiotics should be used reasonably, because most of Klebsiella pneumoniae were multi-drug resistant.

Key words: intensive care unit, hospital acquired infection, pathogen distribution, klebsiella pneumoniae

CLC Number:

R195

Qi Zhili, Liu Pei, Zhuang Haizhou, Duan Meili. Clinical analysis on the nosocomial infections in intensive care unit[J]. Journal of Capital Medical University, 2018, 39(1): 41-44.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2018.01.008

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2018/V39/I1/41

References

[1] Magill S S, Edwards J R, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections[J]. N Engl J Med, 2014,370(13):1198-1208.
[2] Phu V D, Wertheim H F, Larsson M, et al. Burden of hospital acquired infections and antimicrobial use in vietnamese adult intensive care units[J]. PLoS One, 2016,11(1):e0147544.
[3] 王力红,赵霞,张京利.重症监护病房医院感染预防与控制规范[J].中华医院感染学杂志,2017,27(15):3361-3365.
[4] 国家卫生计生委合理用药专家委员会. 2015年全国细菌耐药监测报告[J].中国执业药师, 2016,13(3):3-8.
[5] 贾宁,刘丁,罗爱武,等. 30家医院重症监护室多药耐药菌感染分布特征[J].中华医院感染学杂志, 2017,27(13):2885-2888.
[6] 张小江,郑波,吕媛,等.2012年度全国三级医院重症监护病房来源细菌耐药分析[J].中国临床药理学杂志,2015,31(11):970-975.
[7] 徐庆嵩,宋群波,方芳,等.重症监护室患者医院感染病原菌菌群分布特点及耐药性分析[J].预防医学,2017,29(2):187-190.
[8] 阿依吐拉·卡地尔,关毅. 某三级甲等医院神经内科医院感染目标监测以及空气环境微生物学特征[J].中国煤炭工业医学杂志,2016,19(4):579-583.
[9] 周蓉, 朱卫民, 黄文祥,等. 855株肺炎克雷伯菌感染的临床分布及耐药性分析[J].中国抗生素杂志,2013,38(5):363-369.
[10] Lee C R, Lee J H, Park K S, et al. Global dissemination of carbapenemase-producing klebsiella pneumoniae:epidemiology, genetic context, treatment options, and detection methods[J]. Front Microbiol, 2016, 7:895.
[11] Paczosa M K, Mecsas J. Klebsiella pneumoniae:going on the offense with a strong defense[J]. Microbiol Mol Biol Rev, 2016, 80(3):629-661.
[12] 张水娥, 周齐艳.重症监护病房获得性细菌感染临床调查[J].中华医院感染学杂志,2010,20(7):946-948.
[13] Tzouvelekis L S, Markogiannakis A, Psichogiou M, et al. Carbapenemases in klebsiella pneumoniae and other enterobacteriaceae:an evolving crisis of global dimensions[J]. Clin Microbiol Rev, 2012,25(4):682-707.